Christopher Cao
Christopher Cao is a Cardiothoracic Surgeon at Royal Prince Alfred Hospital, Sydney. He graduated with First Class Honours from the University of New South Wales and scored 99/99 in both steps of the United States Medical Licensing Exam. After his cardiothoracic surgical training with the Royal Australasian College of Surgeons, his specialist Fellowship training was completed at the Memorial Sloan Kettering Cancer Center in New York. He was then invited to be a Faculty Member in the Department of Cardiothoracic Surgery at New York University Medical Center.
Associate Professor Cao has authored or co-authored more than 100 articles in high-impact international scientific journals and textbooks, such as NEJM, Lancet, Lancet Oncology, and Lancet Respiratory Medicine. His PhD with Sydney University was focused on the surgical management of pleural and lung cancers. He is the first author in one of the largest international registries on robotic surgery to date. Christopher’s current academic interest is focused on neoadjuvant immunotherapy for resectable NSCLC, and he hopes to collaborate with medical oncologists in this area of heightened interest.
Christopher’s clinical interests include minimally invasive and robotic thoracic surgery, and he performs one of the highest volumes of these operations in the Asia-Pacific region. He is the first surgeon to perform a number of technically challenging robotic procedures such as sleeve lobectomy resections in Australasia.
Abstracts this author is presenting: